TUSTIN, Calif., May 15, 2012 – To reduce radiation dose while maintaining high image quality, Steinberg Diagnostic Medical Imaging Center (SDMI) in Las Vegas has installed the first Aquilion^TM PRIME 160 series from Toshiba America Medical Systems, Inc. in the U.S. Reinforcing the principle of As Low As Reasonably Achievable (ALARA), SDMI uses Adaptive Iterative Dose Reduction (AIDR) and NEMA XR 25 Dose Check Software to conduct a variety of general imaging exams while minimizing radiation dose. SDMI will soon be upgraded to Toshiba’s recently FDA-cleared AIDR 3D software to further enhance dose reduction and image quality.

“With dose-reduction features such as AIDR, active collimation and dose modulation, the system can make adjustments in real time to reduce radiation exposure while maintaining the image quality needed for diagnoses,” said Dr. Mark Winkler, professor of health sciences at the University of Nevada, Las Vegas, and founding partner of SDMI. “Additionally, the wide, open bore and high-speed rotation make exams more comfortable and quicker for any patient type.”

The Aquilion PRIME can generate 160 unique slices per rotation and features a 7.5- MHU large-capacity tube and 0.35-second scanning. This high-speed rotation allows rapid data acquisition and shortens scan times while the fast reconstruction unit further improves throughput, reducing time required for diagnoses. The system also features a 78-cm aperture gantry, the largest currently available in a high-end CT system. The combination of a 660-pound patient-weight-capacity couch with a large gantry bore makes the Aquilion PRIME an ideal system for use in emergency scanning or bariatric patient studies. 

“Aquilion PRIME was designed for healthcare facilities that need to perform a wide variety of advanced clinical examinations and produce high-quality clinical images with reduced radiation exposure,” said Tim Nicholson, senior manager, Market Development, CT Business Unit, Toshiba. “With Aquilion PRIME, SDMI can conduct many general imaging exams and many advanced applications, like low-dose prospective cardiac CTA.”

About Toshiba America Medical Systems, Inc.

With headquarters in Tustin, Calif., Toshiba America Medical Systems (TAMS) markets, sells, distributes and services diagnostic imaging systems, and coordinates clinical diagnostic imaging research for all modalities in the United States. For more information, visit the TAMS website at www.medical.toshiba.com.

About Toshiba Medical Systems Corporation

Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultrasound, nuclear medicine and MRI systems, as well as information systems for medical institutions. Toshiba Medical Systems Corporation has been providing medical products for over 80 years. Toshiba Medical Systems Corporation is a wholly owned subsidiary of Toshiba.

About Toshiba

Toshiba is a diversified manufacturer and marketer of advanced electronic and electrical products, spanning digital products, such as LCD TVs, notebook PCs and hard disc drives; electronic devices and components, such as semiconductors; social infrastructure systems, including power generation systems; and home appliances. Toshiba was founded in 1875, and today operates a global network of more than 490 companies, with 203,000 employees worldwide and annual sales surpassing 6.3 trillion yen (US$77 billion).

TUSTIN, Calif., May 14, 2012 – Kaleida Health’s Gates Stroke Center (GSC) at the Gates Vascular Institute in Buffalo, N.Y., a world-class neurological and stroke care center, recently completed the second phase of its study analyzing the patient and fiscal benefits of using Toshiba America Medical System, Inc.’s Aquilion^TM ONE CT system in diagnosing acute stroke. GSC achieved $1.31 million in annualized cost savings, a reduction in patient length of stay and improved discharge dispositions as a result of its multidisciplinary approach, enhanced education and training, and advanced Aquilion ONE CT imaging technology. These results are particularly important, as containing costs while delivering high-quality, effective care is a directive of healthcare reform. GSC was formerly the Kaleida Stroke Center at Millard Fillmore Gates Circle Hospital.

GSC set out to quantify the benefits of the Aquilion ONE in stroke diagnosis through a non-controlled study, evaluating imaging procedures, inpatient length of stay and discharge disposition. The study compared inpatient data sets from July to September 2007, prior to the Aquilion ONE installation, with data sets from July to September 2009 (phase one) and July to September 2010 (phase two), which utilized the Aquilion ONE and addressed the top three discharging ICD-9-CM codes.

“Being able to perform whole brain perfusion and digital angiography with the Aquilion ONE has enabled more efficient and accurate stroke diagnoses, while resulting in tremendous patient and cost savings benefits,” said Elad Levy, MD, FACS, FAHA, professor of Neurosurgery and Radiology, University at Buffalo Neurosurgery, and director of Endovascular Stroke Service, GSC. “The study also shows year-over-year improvements as we continue to find additional ways to maximize the technology.”

Highlights of the findings include (full data set on file):

Length of Stay Data

Chart Caption: GSC’s use of the Aquilion ONE in diagnosing acute stroke resulted in a significant reduction in patient length of stay that continues to improve.

Change in Discharge Disposition

Chart Caption: Diagnosing stroke with the Aquilion ONE improved the discharge disposition for patients at GSC. For example, patients falling under ICD-9-CM 434.11, the most resource intensive code, saw a 48 percent reduction in patients discharged to rehab in the 2010 data.

Healthcare Cost Savings

Chart Caption: In total, over the past two years GSC has achieved more than $2 million in annualized savings by using the Aquilion ONE to diagnose stroke.

“Our partnership with GSC is a perfect example of Toshiba working directly with customers to improve patient outcomes and reduce overall healthcare costs,” Tim Nicholson, senior manager, Market Development, CT Business Unit, Toshiba. “In today’s healthcare landscape, the results of this two-year study are more important than ever and are achievable for other institutions with a multidisciplinary collaboration and advanced imaging technology like the Aquilion ONE.”

About Toshiba America Medical Systems, Inc.

With headquarters in Tustin, Calif., Toshiba America Medical Systems (TAMS) markets, sells, distributes and services diagnostic imaging systems, and coordinates clinical diagnostic imaging research for all modalities in the United States. For more information, visit the TAMS website at www.medical.toshiba.com.

About Toshiba Medical Systems Corporation

Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultrasound, nuclear medicine and MRI systems, as well as information systems for medical institutions. Toshiba Medical Systems Corporation has been providing medical products for over 80 years. Toshiba Medical Systems Corporation is a wholly owned subsidiary of Toshiba.

About Toshiba

Toshiba is a diversified manufacturer and marketer of advanced electronic and electrical products, spanning digital products, such as LCD TVs, notebook PCs and hard disc drives; electronic devices and components, such as semiconductors; social infrastructure systems, including power generation systems; and home appliances. Toshiba was founded in 1875, and today operates a global network of more than 490 companies, with 203,000 employees worldwide and annual sales surpassing 6.3 trillion yen (US$77 billion).

Toshiba’s Infinix-i Systems Ideal in Planning and Guiding TAVR Procedures

LAS VEGAS, May 9, 2012 – To better facilitate transcatheter aortic valve replacement (TAVR) procedures, Toshiba America Medical Systems, Inc. introduces two new software enhancements that complement its Infinix™-i cardiovascular X-ray systems. The Infinix-i systems will now utilize software from Pie Medical Imaging BV – 3mensio Valve™ and CAAS A-Valve™. The new software will be showcased at this year’s Society for Cardiovascular Angiography and Interventions (SCAI) Scientific Sessions in Las Vegas, May 9 – 12, 2012 (Booth #522).

The 3mensio Valve software is used in planning TAVR procedures to visualize and analyze the aortic root and access routes. The 3mensio Valve screen is displayed in the Infinix-i procedure room to show the delivery pathway, 3D structure of the aortic root and calcifications present. CAAS A-Valve is utilized during the intervention. It uses two angiography X-ray projections to create a 3D reconstruction of the aortic root, providing the best visualization angle to move the Infinix-i C-arm into this optimal projection. To further enhance workflow, real-time measurements can be performed on the 2D and 3D images.

Toshiba’s Infinix-i moves like a hovercraft, offering unrestricted patient access and C-arm movement with high-resolution images, enabling physicians to conduct advanced TAVR procedures with maximum efficiency and efficacy. The system’s flexible design streamlines valve replacement procedures, as physicians can obtain a wide range of imaging angles without repositioning the patient. The combination of the Infinix-i system design and mechanics with advanced visualization techniques creates the ideal lab for TAVR procedures.

Toshiba’s Newest Ultrasound Systems Showcased at the Leading Edge in Diagnostic Ultrasound Annual Conference

ATLANTIC CITY, N.J., May 8, 2012 – Toshiba America Medical Systems, Inc. will showcase the Aplio^TM 500 and Aplio 300 ultrasound systems at the Leading Edge in Diagnostic Ultrasound Annual Conference, May 8 – 11, 2012, in Atlantic City, N.J. (Booth #103). Both systems combine advanced visualization capabilities, workflow automation tools and superior ergonomics, for improved departmental efficiency and greater patient access.

Toshiba’s Aplio 500 offers picture-perfect imaging with advanced visualization features, including Fly Thru and Smart Fusion. An industry-first technology, Fly Thru uses 4D ultrasound to “fly through” interiors of fluid-filled ducts and vessels for better exploration of lesions and masses and to assist in planning interventional procedures. Smart Fusion combines the best in imaging and synchronizes CT or MR with ultrasound, helping to locate hard-to-find lesions and aiding in ultrasound-guided biopsies.

The Aplio 300 offers exceptional image quality in a smaller, more versatile platform designed to be a clinical workhorse for all routine ultrasound exams. Aplio 300 comes standard with the same advanced workflow tools and ergonomics as the Aplio 500 system, including the iStyle^TM+ Productivity Suite.

“Both of our newest ultrasound systems provide clinicians with unique capabilities designed to meet the needs of any hospital,” said Tomohiro Hasegawa, director, Ultrasound Business Unit, Toshiba. “Aplio 500, Toshiba’s flagship ultrasound system, has advanced features to help improve ultrasound diagnoses, while the Aplio 300 is a versatile system designed for many routine exams.”

About Toshiba America Medical Systems, Inc.

With headquarters in Tustin, Calif., Toshiba America Medical Systems (TAMS) markets, sells, distributes and services diagnostic imaging systems, and coordinates clinical diagnostic imaging research for all modalities in the United States. For more information, visit the TAMS website at www.medical.toshiba.com.

About Toshiba Medical Systems Corporation

Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultrasound, nuclear medicine and MRI systems, as well as information systems for medical institutions. Toshiba Medical Systems Corporation has been providing medical products for over 80 years. Toshiba Medical Systems Corporation is a wholly owned subsidiary of Toshiba.

About Toshiba

Toshiba is a diversified manufacturer and marketer of advanced electronic and electrical products, spanning digital products, such as LCD TVs, notebook PCs and hard disc drives; electronic devices and components, such as semiconductors; social infrastructure systems, including power generation systems; and home appliances. Toshiba was founded in 1875, and today operates a global network of more than 490 companies, with 203,000 employees worldwide and annual sales surpassing 6.3 trillion yen (US$77 billion).

“Toshiba offers innovative technology and dependable, responsive support, resulting in a customer-focused approach that is unmatched in the industry,” said Don Fowler, president and CEO, Toshiba. “Calum’s leadership in business operations will ensure that Toshiba continues to achieve high customer satisfaction, from point of sale and installation to training and customer support.”

In his role, Cunningham will oversee a range of activities, from national quotes and bids, to market data submissions and reporting. He is also responsible for sales logistics management, including warehouse logistics, customer site planning, installation support, clinical applications and service training.

Cunningham joined Toshiba in 2009 as senior vice president and general manager of Toshiba Medical Visualization Systems. Upon Toshiba’s merger with Vital in 2011, he was named executive vice president, Corporate & Business Development at Vital.  

Prior to joining Toshiba, Cunningham held noteworthy management and business operations positions at Barco Medical Advanced Visualization, Earthport PLC and DigitalBrain PLC. Cunningham spent 10 years with Intel Corporation, where he held a number of senior engineering and operations management roles before becoming founder and general manager of Intel’s global Performance Learning Solutions business. He also has served as an advisor to governments in the UK, Ireland and South Africa on the use of information and communication technologies for medicine and education.

About Toshiba America Medical Systems, Inc.

With headquarters in Tustin, Calif., Toshiba America Medical Systems (TAMS) markets, sells, distributes and services diagnostic imaging systems, and coordinates clinical diagnostic imaging research for all modalities in the United States. For more information, visit the TAMS website at www.medical.toshiba.com.

About Toshiba Medical Systems Corporation

Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultrasound, nuclear medicine and MRI systems, as well as information systems for medical institutions. Toshiba Medical Systems Corporation has been providing medical products for over 80 years. Toshiba Medical Systems Corporation is a wholly owned subsidiary of Toshiba.

About Toshiba

Toshiba is a diversified manufacturer and marketer of advanced electronic and electrical products, spanning digital products, such as LCD TVs, notebook PCs and hard disc drives; electronic devices and components, such as semiconductors; social infrastructure systems, including power generation systems; and home appliances. Toshiba was founded in 1875, and today operates a global network of more than 490 companies, with 203,000 employees worldwide and annual sales surpassing 6.3 trillion yen (US$77 billion).

Aplio 500 and Aplio 300 Showcased at LARS Spring Diagnostic Ultrasound Conference

PASADENA, Calif., May 5, 2012 – Toshiba America Medical Systems, Inc. will showcase the Aplio^TM 500 and Aplio 300 ultrasound systems at the Los Angeles Radiological Society (LARS) Spring Diagnostic Ultrasound Conference, May 5 – 6, 2012, in Pasadena, Calif. (Booth #1). Aplio 500 and Aplio 300, the latest additions to Toshiba’s ultrasound product line, combine advanced visualization capabilities, workflow automation tools and superior ergonomics, for improved departmental efficiency and greater patient access.

Toshiba’s Aplio 500 offers picture-perfect imaging with advanced visualization features, including Fly Thru and Smart Fusion. An industry-first technology, Fly Thru uses 4D ultrasound to “fly through” interiors of fluid-filled ducts and vessels for better exploration of lesions and masses and to assist in planning interventional procedures. Smart Fusion combines the best in imaging and synchronizes CT or MR with ultrasound, helping to locate hard-to-find lesions and aiding in ultrasound-guided biopsies.

The Aplio 300 offers exceptional image quality in a smaller, more versatile platform designed to be a clinical workhorse for all routine ultrasound exams. Aplio 300 comes standard with the same advanced workflow tools and ergonomics as the Aplio 500 system, including the iStyle^TM+ Productivity Suite.

“Toshiba’s new ultrasound systems are designed to meet the clinical needs of hospitals everywhere,” said Tomohiro Hasegawa, director, Ultrasound Business Unit, Toshiba. “Aplio 500, Toshiba’s flagship ultrasound system, has advanced features to help improve ultrasound diagnoses, while the Aplio 300 is a versatile system designed for many routine exams.”

About Toshiba America Medical Systems, Inc.

With headquarters in Tustin, Calif., Toshiba America Medical Systems (TAMS) markets, sells, distributes and services diagnostic imaging systems, and coordinates clinical diagnostic imaging research for all modalities in the United States. For more information, visit the TAMS website at www.medical.toshiba.com.

About Toshiba Medical Systems Corporation

Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultrasound, nuclear medicine and MRI systems, as well as information systems for medical institutions. Toshiba Medical Systems Corporation has been providing medical products for over 80 years. Toshiba Medical Systems Corporation is a wholly owned subsidiary of Toshiba.

About Toshiba

Toshiba is a diversified manufacturer and marketer of advanced electronic and electrical products, spanning digital products, such as LCD TVs, notebook PCs and hard disc drives; electronic devices and components, such as semiconductors; social infrastructure systems, including power generation systems; and home appliances. Toshiba was founded in 1875, and today operates a global network of more than 490 companies, with 203,000 employees worldwide and annual sales surpassing 6.3 trillion yen (US$77 billion).

TUSTIN, Calif., April 30, 2012 – Toshiba America Medical Systems, Inc. announces the FDA clearance of the Aquilion^TM PRIME 80 series CT system, the latest addition to the Aquilion CT product line. Producing high-quality clinical images and reducing radiation exposure with Adaptive Iterative Dose Reduction 3D (AIDR 3D), the system can generate 80 unique slices per rotation. The Aquilion PRIME 80 series, designed with in-field upgradeability to 160 slices, gives healthcare facilities the ability to perform a wide variety of advanced clinical procedures today and to grow as clinical needs expand.

The Aquilion PRIME features a 0.5 mm detector, a 7.5 MHU large-capacity tube and 0.35 second scanning. This high-speed rotation allows rapid data acquisition and shortens scan times while the fast reconstruction unit further improves throughput, all of which help provide faster, safer and more accurate diagnoses. The system also features a 78 cm aperture gantry, the largest currently available in a high-end CT system. The combination of a 660-pound patient-weight-capacity couch with a large gantry bore makes the Aquilion PRIME 80 series an ideal system for routine clinical scanning or bariatric patient studies. 

To reinforce the principle of As Low As Reasonably Achievable (ALARA) imaging, AIDR 3D and NEMA XR 25 Dose Check Software are standard features on the Aquilion PRIME 80 series. AIDR 3D, the newest dose-reduction technology for the Aquilion CT product line, is an iterative process that helps to remove noise from the image with reduced radiation dose. Toshiba’s NEMA XR 25 Dose Check Software enhances user awareness of the radiation dose being administered to patients. This software includes Dose Alert and Dose Notification, addressing the two main components of MITA’s CT Dose Check Initiative, as well as Tracking and Digital Imaging and Communications in Medicine (DICOM), to further enhance dose awareness.

“The PRIME 80 series is an example of how Toshiba constantly develops new technologies to improve safety in imaging and patient care,” said Tim Nicholson, senior manager, Market Development, CT Business Unit, Toshiba. “Giving hospitals the opportunity to conduct advanced exams in mere seconds and grow clinical abilities based on patient needs results in improved patient care and overall departmental efficiency.”

About Toshiba America Medical Systems, Inc.

With headquarters in Tustin, Calif., Toshiba America Medical Systems (TAMS) markets, sells, distributes and services diagnostic imaging systems, and coordinates clinical diagnostic imaging research for all modalities in the United States. For more information, visit the TAMS website at www.medical.toshiba.com

About Toshiba Medical Systems Corporation

Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultrasound, nuclear medicine and MRI systems, as well as information systems for medical institutions. Toshiba Medical Systems Corporation has been providing medical products for over 80 years. Toshiba Medical Systems Corporation is a wholly owned subsidiary of Toshiba.

About Toshiba

Toshiba is a diversified manufacturer and marketer of advanced electronic and electrical products, spanning digital products, such as LCD TVs, notebook PCs and hard disc drives; electronic devices and components, such as semiconductors; social infrastructure systems, including power generation systems; and home appliances. Toshiba was founded in 1875, and today operates a global network of more than 490 companies, with 203,000 employees worldwide and annual sales surpassing 6.3 trillion yen (US$77 billion).

VANCOUVER, British Columbia, April 26, 2012 – Full-face transplants are new, breakthrough medical procedures that dramatically alter the lives of patients suffering from severe facial disfiguration. At this year’s American Roentgen Ray Society (ARRS) Annual Meeting (Vancouver, British Columbia, April 29 – May 4, 2012), Frank J. Rybicki, M.D., Ph.D.; director, Applied Imaging Science Laboratory; director, Cardiac CT and Vascular CT/MRI, Brigham and Women’s Hospital, Department of Radiology; and associate professor, Harvard Medical School, will discuss the role that imaging plays in face transplants during a presentation titled “Wide Area Detector CT Imaging with Face Transplantation.”

In the presentation held on Monday, April 30, 2012, from 12:00 p.m. – 1:00 p.m., Dr. Rybicki will discuss cardiovascular applications of wide area detector CT, as well as imaging of key anatomy for surgical planning support by mapping spatial relationships between blood vessels for surgical anastomoses and other facial structures. Time-resolved CT also separates arteries and veins, and there are potential applications for blood flow.

Toshiba’s Aquilion^TM ONE dynamic volume CT system can capture the entire heart or brain in one rotation and covers up to 16 cm of anatomy using 320 ultra-high-resolution 0.5 mm detector elements. The system can also show an organ’s dynamic blood flow and real-time function.

“The high spatial resolution, quick acquisition time and wide-volume coverage of the Aquilion ONE make this system a good fit for planning complex procedures like face transplantation,” said Tim Nicholson, senior manager, Market Development, CT Business Unit, Toshiba. “Working with one of the world’s leading healthcare institutions, we continue to find new and exciting ways to maximize the Aquilion ONE’s technology.”

About Toshiba America Medical Systems, Inc.

With headquarters in Tustin, Calif., Toshiba America Medical Systems (TAMS) markets, sells, distributes and services diagnostic imaging systems, and coordinates clinical diagnostic imaging research for all modalities in the United States. For more information, visit the TAMS website at www.medical.toshiba.com.

About Toshiba Medical Systems Corporation

Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultrasound, nuclear medicine and MRI systems, as well as information systems for medical institutions. Toshiba Medical Systems Corporation has been providing medical products for over 80 years. Toshiba Medical Systems Corporation is a wholly owned subsidiary of Toshiba.

About Toshiba

Toshiba is a diversified manufacturer and marketer of advanced electronic and electrical products, spanning digital products, such as LCD TVs, notebook PCs and hard disc drives; electronic devices and components, such as semiconductors; social infrastructure systems, including power generation systems; and home appliances. Toshiba was founded in 1875, and today operates a global network of more than 490 companies, with 203,000 employees worldwide and annual sales surpassing 6.3 trillion yen (US$77 billion).

Dose-Reduction Software Makes CT Exams Safer, Improves Image Quality 

TUSTIN, Calif., April 25, 2011 – Toshiba America Medical Systems, Inc. announces the FDA clearance of Adaptive Iterative Dose Reduction 3D (AIDR 3D), the company’s newest dose-reduction technology. Toshiba will offer the AIDR 3D software upgrade and related training, complimentary, to all existing Aquilion™ ONE, Aquilion Premium and Aquilion PRIME CT customers.

AIDR 3D is Toshiba’s third generation iterative dose reconstruction software that incorporates significant system enhancements by reducing radiation dose compared to conventional scanning. It is a sophisticated algorithm designed to work in both the raw data and image data space, reducing noise while attempting to maintain image quality.

AIDR 3D can also be seamlessly integrated with ^SUREExposure^TM 3D, a software that calculates the minimum radiation exposure required for every exam. ^SUREExposure 3D adjusts the dose for each patient based on a pre-set, targeted level of image quality.  

“Toshiba is constantly developing new technologies that help to improve imaging and patient care,” said Tim Nicholson, senior manager, Market Development, CT Business Unit, Toshiba. “With the introduction of AIDR 3D, Toshiba is continuing its commitment to offering advanced dose reduction technologies.”

About Toshiba America Medical Systems, Inc.

With headquarters in Tustin, Calif., Toshiba America Medical Systems (TAMS) markets, sells, distributes and services diagnostic imaging systems, and coordinates clinical diagnostic imaging research for all modalities in the United States. For more information, visit the TAMS website at www.medical.toshiba.com.

About Toshiba Medical Systems Corporation

Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultrasound, nuclear medicine, and MRI systems, as well as information systems for medical institutions. Toshiba Medical Systems Corporation has been providing medical products for over 80 years. Toshiba Medical Systems Corporation is a wholly owned subsidiary of Toshiba.

About Toshiba

Toshiba is a diversified manufacturer and marketer of advanced electronic and electrical products, spanning digital products, such as LCD TVs, notebook PCs and hard disc drives; electronic devices and components, such as semiconductors; social infrastructure systems, including power generation systems, and home appliances. Toshiba was founded in 1875, and today operates a global network of more than 490 companies, with 203,000 employees worldwide and annual sales surpassing 6.3 trillion yen (US$77 billion).

CHICAGO, April 16, 2012 — Performing pediatric cardiovascular interventions requires imaging equipment specifically designed for the setting. With superior access to both patient and equipment, Toshiba America Medical Systems, Inc.’s Infinix™-i bi-plane cardiovascular X-ray system will be used during two live pediatric cases at the Pediatric and Adult Interventional Cardiac Symposium (PICS-AICS), April 15–18, 2012, in Chicago.

The live cases will be performed on Tuesday, April 17, 2012, by leading interventional cardiologists:

• Rush University Medical Center, Chicago — Ziyad M. Hijazi, M.D., and Zahid Amin, M.D.
• Nationwide Children’s Hospital, Columbus, Ohio — John P. Cheatham, M.D.

Toshiba’s Infinix-i systems feature an industry-leading five-axis positioner, allowing for unrestricted patient access to facilitate advanced, complex procedures with ease. Infinix-i’s design, system mechanics and tableside dose reduction features all contribute to faster exam times and safer procedures.

“During pediatric interventions, the Infinix-i moves like a hovercraft, with C-arm movement that enables physicians to obtain difficult-to-reach imaging angles for more efficient diagnoses and treatment,” said Stephen Bumb, director, X-ray Vascular Business Unit, Toshiba. “The PICS-AICS live cases provide real-life clinical examples of how Toshiba’s technology improves patient care in the cath lab.”

About Toshiba America Medical Systems, Inc.

With headquarters in Tustin, Calif., Toshiba America Medical Systems (TAMS) markets, sells, distributes and services diagnostic imaging systems, and coordinates clinical diagnostic imaging research for all modalities in the United States. For more information, visit the TAMS website at www.medical.toshiba.com.

About Toshiba Medical Systems Corporation

Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultrasound, nuclear medicine and MRI systems, as well as information systems for medical institutions. Toshiba Medical Systems Corporation has been providing medical products for over 80 years. Toshiba Medical Systems Corporation is a wholly owned subsidiary of Toshiba.

About Toshiba

Toshiba is a diversified manufacturer and marketer of advanced electronic and electrical products, spanning digital products, such as LCD TVs, notebook PCs and hard disc drives; electronic devices and components, such as semiconductors; social infrastructure systems, including power generation systems; and home appliances. Toshiba was founded in 1875, and today operates a global network of more than 490 companies, with 203,000 employees worldwide and annual sales surpassing 6.3 trillion yen (US$77 billion).